| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Entomology, Iowa State University, Ames, IA 50011, USA
Correspondence
Bryony C. Bonning
bbonning{at}iastate.edu
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Present address: USDA, ARS, Beltsville, MD 20705, USA. 
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). BVs are produced and released from the infected cells and establish secondary infection of other tissues within the host. At the very late phase of infection, polyhedra are generated in massive quantities. Following death of the host, the cadaver lyses, releasing polyhedra into the environment. Because of their pathogenicity and environmental safety, baculoviruses have been studied as potential biological control agents and used successfully for the management of several insect pests (Moscardi, 1999). Baculovirus insecticides have not been adopted widely, however, in part because of their relatively slow action. Insect pests infected with wild-type baculoviruses may continue to feed and cause crop damage for days and thus often fail to compete with conventional chemical insecticides. Recombinant baculoviruses expressing genes that encode a variety of insect-specific toxins or development-disrupting enzymes and hormones kill insects more rapidly and reduce feeding damage compared with larvae infected with wild-type baculoviruses (Kamita et al., 2005).
Host basement membranes (BMs) have been identified as a potential target for improving baculovirus insecticidal efficacy (Keddie et al., 1989). The BM is an extracellular protein sheet surrounding all tissues of animals, composed primarily of laminin, collagen IV and proteoglycans. The BM functions in cell adhesion, cell signalling and maintenance of tissue structure (Yurchenco & O'Rear, 1993). There is high homology between the BM of invertebrates and vertebrates in composition, structure and function (Fessler & Fessler, 1989). As described for other viruses (Romoser et al., 2005), BMs appear to act as a barrier to dissemination of baculoviruses within infected insects. BVs are too large to diffuse freely through the pores in the BM that surround tissues of the host insect (Reddy & Locke, 1990). Co-injection of BVs and clostridial collagenase, a protease known to degrade BM, resulted in enhanced infection of host tissues (Smith-Johannsen et al., 1986). An ultrastructural study of infection by the baculovirus Cydia pomonella granulovirus revealed a substantial accumulation of BVs in the extracellular spaces between BMs and the plasma membranes of midgut and fat body cells (Hess & Falcon, 1987). Collectively, these observations suggest that insect BM inhibits the movement of BVs.
To see whether disruption of the BM could augment dissemination of BV within an infected host, a recombinant baculovirus, AcMLF9.ScathL, was constructed to express a BM-degrading cathepsin L (EC3.4.22.15) from the flesh fly, Sarcophaga peregrina Robineau-Desvoidy (Harrison & Bonning, 2001). In the flesh fly, this cathepsin L (ScathL) degrades two components of the BM (Homma & Natori, 1996). The recombinant virus AcMLF9.ScathL killed Heliothis virescens larvae approximately 30 % faster than a virus expressing a scorpion venom-derived neurotoxin and over 50 % faster than the wild-type virus. Larvae infected with AcMLF9.ScathL consumed fivefold less lettuce than wild-type virus-infected larvae. Interestingly, AcMLF9.ScathL caused fragmentation of internal tissues and melanization of infected H. virescens larvae prior to death. Wild-type baculovirus-infected larvae typically melanize after death.
We have tested a number of hypotheses to understand the mechanisms underlying the significantly enhanced insecticidal efficacy of the recombinant baculovirus AcMLF9.ScathL. Here, we describe experiments to test the hypothesis that ScathL damages the BM barrier to virus dissemination, allowing more rapid spread or altered tissue tropism of the virus.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
) were maintained in TC-100 medium (Sigma) supplemented with 10 % fetal bovine serum (FBS; Intergen) and antibiotics (1 U penicillin ml–1, 1 µg streptomycin ml–1; Sigma). Trichoplusia ni BTI-TN-5B1-4 (High Five) cells (Wickham et al., 1992) were maintained in Ex-Cell 405 medium (JRH Biosciences) supplemented with antibiotics only. Both cell lines were maintained at 28 °C. Larvae of H. virescens were reared individually from eggs (BioServ, Frenchtown, NJ, USA) on an artificial diet in 1 oz plastic cups (BioServ) at 28 °C with a 14 : 10 h light : dark cycle.
The wild-type C6 strain of Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and the recombinant viruses AcMLF9.ScathL (Harrison & Bonning, 2001) and AcMLF9.ScathL.C146A were used for this study. AcMLF9.ScathL expresses a functional flesh fly cathepsin L protease (ScathL), whilst AcMLF9.ScathL.C146A, constructed in the present study, expresses a catalytic site mutant of ScathL. The expression of both proteins was directed by the AcMNPV p6.9 promoter (Harrison & Bonning, 2000; Hill-Perkins & Possee, 1990). Additional recombinant viruses were constructed to express ScathL or ScathL.C146A along with either 
-galactosidase or chloramphenicol acetyltransferase (CAT) (see below). Budded virus stocks were produced in Sf21 cells and polyhedra were generated and purified as described previously (Harrison & Bonning, 2001), resuspended in glycerin and water (3 : 2, v/v), quantified using a haemocytometer and stored at 4 °C. BV stocks were titrated by end-point dilution (Summers & Smith, 1987).
Construction of recombinant viruses.
To construct the control virus AcMLF9.ScathL.C146A, site-directed mutagenesis of the ScathL sequence was carried out to substitute the catalytic cysteine residue at position 146 with alanine. The mutated ScathL gene (designated ScathL.C146A) was cloned back into the BglII site of the pAcMLF9 transfer vector (Harrison & Bonning, 2000). This transfer vector allows production of polyhedrin-positive viruses with protein expression driven by the AcMNPV p6.9 promoter (Hill-Perkins & Possee, 1990).
To construct recombinant baculoviruses carrying reporter genes, the hsp70/lacZ expression cassette was amplified from a recombinant Rachiplusia ou MNPV (RoPEP.hsp70/lacZ) in which hsp70/lacZ had been inserted into the polyhedral envelope protein gene (Jin, 2002). The primers used were pp342 (5'-CTCCTCATTGCAGACCTC-3'), which hybridized upstream of an XbaI site next to the hsp70/lacZ cassette, and HlAcXBSV (5'-CTAGTCTAGAAGATCTGATCCAGACATGATAAGATACATTG-3'), which hybridized to the 3' end of the hsp70/lacZ simian virus 40 (SV40) poly(A+) signal and contained an XbaI site (underlined).
A CAT expression cassette was PCR amplified from the recombinant virus vSynXIV VI+CAT, which expresses CAT from a very strong tandem baculovirus late/very late promoter array (Wang et al., 1991) The primers used were 6031 (5'-GATTCACAGTTAATTTGCGAC-3'), which hybridizes upstream of an XbaI site flanking the CAT cassette, and SynCAT5X (5'-CTAGTCTAGAGGGCCAAGCTTGGCGTTATTG-3'), which contains an XbaI site (underlined). After PCR amplification, the hsp70/lacZ and CAT PCR products were digested with XbaI and ligated into the XbaI sites of pAcMLF9.ScathL and pAcMLF9.ScathL.C146A between the polh gene and p6.9/ScathL or p6.9/ScathL.C146A cassette (Fig. 1). Recombinant viruses were obtained through homologous recombination by co-transfection of Sf21 cells with Bsu36I-linearized AcRP23.lacZ viral DNA (Kitts et al., 1990) using calcium phosphate precipitation (O'Reilly et al., 1992). Recombinant viruses were isolated by four rounds of plaque assay (Summers & Smith, 1987). Purified recombinant virus clones were checked for correct insertion of the foreign sequence by restriction enzyme analysis, PCR amplification and sequencing of the region where the gene was inserted. Expression of ScathL or ScathL.C146A and the reporter genes (lacZ and CAT) by the recombinant viruses were confirmed by Western blotting and activity assays (Harrison & Bonning, 2001).
|
). For lethal concentration bioassays, all viruses were assayed against neonate H. virescens larvae as described previously with three replicates of 30 larvae per virus concentration (Harrison & Bonning, 2001). Larval mortality was scored after mock-infected larvae had pupated. Median lethal concentration (LC50) values (polyhedra ml–1) were calculated by POLO probit analysis and compared by standard lethal dose ratio comparison (Robertson & Preisler, 1992).
In time–mortality bioassays, the 99 % lethal concentration (LC99) (polyhedra ml–1) for each virus was calculated from the dose–mortality bioassay data and used as an inoculation dose in droplet feeding bioassays of neonate H. virescens. Mortality was recorded every 2–8 h until the mock-infected larvae and any larvae that survived the virus treatments had pupated. Median survival times (ST50) values were calculated using the Kaplan–Meier estimator and compared by log-rank test (Kalbfleisch & Prentice, 1980). Three replicates were conducted for each virus with 30 neonates per replicate.
Quantification of BV and polyhedra production.
To measure production of progeny BV and polyhedra in larvae, newly moulted fifth-instar larvae within 1 h of ecdysis of the fourth-instar cuticle were inoculated using a microapplicator (Burkard Scientific) for direct delivery of a polyhedral suspension (1 µl) into the midgut, as described previously (Washburn et al., 1995). For BV titre assays, infected larvae at 24, 48 and 72 h post-inoculation (p.i.) were anaesthetized on ice and surface sterilized in 70 % ethanol. Haemolymph was collected from an incision in a proleg directly onto a piece of Parafilm on ice. Ten microlitres of haemolymph per larva was transferred into a 1.5 ml sterile tube containing 90 µl TC-100 medium supplemented with 10 % FBS, antibiotics (1 U penicillin ml–1, 1 µg streptomycin ml–1; Sigma) and 0.003 % 1-phenyl-2-thiourea (PTU) to prevent melanization. The samples were mixed well and placed on ice. The diluted haemolymph samples were centrifuged at 500 g for 5 min and the cell-free plasma used to determine the BV titre by end-point dilution (Summers & Smith, 1987). Sixteen larvae were tested at each time point for each virus and the experiment was repeated twice. Means of TCID50 values ml–1 in log scale were analysed for statistical significance among the three viruses in a one-way analysis of variance (ANOVA) using SAS (SAS Institute, 1990).
To determine any potential adverse effect of ScathL expression on the virus itself, progeny BV titres from infections of Sf21 cells with AcMLF9.ScathL.hsp70/lacZ, AcMLF9.ScathL.C146A.hsp70/lacZ and wild-type AcMNPV C6 were also compared. Sf21 cells in 35 mm culture dishes (1x106 cells per dish) were infected with BV at an m.o.i. of 0.1. Infected cell culture medium was harvested at 48, 96 and 144 h p.i. and titrated by end-point dilution.
For quantification of polyhedra, larvae at 72 h p.i. or cadavers were weighed individually and groups of three larvae or cadavers were selected randomly for isolation of polyhedra, as described previously (Harrison & Bonning, 2001). Six groups of larvae or cadavers were processed for each treatment. Polyhedra were counted using a haemocytometer and counts were analysed by one-way ANOVA.
Visualization of the course of infection by expression of -galactosidase.
Newly moulted fifth-instar larvae of H. virescens were inoculated orally with 5.0x105 polyhedra per larva of AcMLF9.ScathL.hsp70/LacZ or AcMLF9.ScathL.C146A.hsp70/LacZ. Every 6 h, haemolymph from infected larvae was collected as described above. Ten to fifteen microlitres of haemolymph per larva was transferred into a 1.5 ml sterile tube containing 50 µl TC-100 medium and mixed, and then 10 µl of the mixture was transferred into a well of a 96-well culture plate containing 70 µl TC-100 medium with 10 % FBS. After attachment, haemocytes were processed for lacZ expression as described previously (Trudeau et al., 2001). Plates were maintained in the dark overnight and examined for blue coloration under an inverted microscope. The percentage of LacZ-positive haemocytes was determined by first examining 1000–5000 haemocytes for each well of samples harvested at 12, 18 and 24 h p.i. When the percentage of LacZ-positive haemocytes in a well exceeded 1 %, 200 haemocytes were selected randomly and the numbers of positive and negative cells were recorded.
After haemolymph collection, larvae were dissected and whole mounts were made (Washburn et al., 2000). Larval tissues were observed under a dissection microscope to assess the presence and distribution of blue coloration indicative of virus infection. Data were recorded for the gut, trachea, fat body and Malphigian tubules. The mean percentage of larvae with virus infection of each tissue at each time point was calculated from observations of three replicates, each with eight larvae for each virus. One-way ANOVA was performed to test for statistical significance of infection rate between the two viruses.
Quantification of the extent of virus infection by CAT activity assay.
To quantify the extent of virus infection, CAT activity assays were conducted on tissues from H. virescens larvae infected with AcMLF9.ScathL.CAT or AcMLF9.ScathL.C146A.CAT. Newly moulted fifth-instar larvae were inoculated orally with 5.0x105 polyhedra per larva. At 6 h p.i., infected larvae were bled and dissected every 6 h for assay of CAT activity in the haemolymph and excised tissues. Haemolymph extracted from three larvae from the same treatment was pooled in a 1.5 ml tube containing 100 µl 250 mM Tris/HCl (pH 7.8) on dry ice. Gut or fat body tissues excised from three larvae were pooled in a 1.5 ml tube containing 100 µl 250 mM Tris/HCl (pH 7.8) on dry ice. The samples were stored at –80 °C until further processing. Gut and fat body samples were homogenized for 1 min with a plastic pestle and then refrozen at –80 °C for 10 min. The refrozen samples were thawed in a 37 °C water bath for 1 min, followed by vortexing for 1 min. Haemolymph samples were subjected to three freeze–thaw cycles. All samples were heated at 6 °C for 15 min to inactivate deacetylases. After centrifugation at 10 000 g for 2 min, the supernatants were stored at –80 °C prior to CAT activity and protein assays. Specific CAT activity (c.p.m. min–1 mg–1) was assayed for all samples as described previously using [3H]acetyl-CoA (Dai et al., 2004). Protein concentrations of the samples were determined using a Bio-Rad protein assay (Bio-Rad) with BSA as a standard (Bradford, 1976). A total of 30 larvae (ten replicates) were tested for each time point for each virus treatment. Mock (water)-inoculated larvae served as control treatments. The specific activity data were analysed by one-way ANOVA.
Protease assays.
Newly moulted fifth-instar larvae were inoculated orally with 5.0x105 polyhedra per larva. Mock treatments were inoculated with water. At 12, 24 and 48 h p.i., larvae were bled and dissected as described above. The haemolymph samples from three larvae from the same treatment were pooled in a 1.5 ml tube containing 1 µl 0.3 % PTU as a replicate. Five replicates were processed for each treatment. Haemolymph samples were centrifuged at 500 g for 5 min at 4 °C to separate haemocytes and plasma. Ten microlitres of plasma was promptly transferred for each sample into a tube containing 10 µl 2x SDS loading buffer, heated immediately at 95 °C for 10 min and stored at –20 °C until Western blot analysis. The remaining plasma was transferred into clean tubes containing 100 µl 0.1 M sodium acetate buffer (pH 5.0), the haemocyte pellets were resuspended in 50 µl of the same buffer and these samples were stored at –80 °C prior to analysis.
The gut (minus the food bolus) and fat body were excised from the three bled larvae and placed separately into 1.5 ml tubes containing 100 µl 0.1 M sodium acetate buffer on dry ice for ScathL activity assays. Excised tissues were homogenized with a plastic pestle for 1 min. Prior to homogenization, 5 µl 100 mM PMSF was added to each gut sample. Samples were centrifuged at 10 000 g for 5 min at 4 °C and the supernatants transferred to clean tubes. Western blot analysis was conducted using 15 µg total protein for each sample to examine the expression and molecular size of ScathL in the haemocytes, plasma, fat body and gut tissues. Anti-ScathL antisera were produced in two New Zealand White rabbits against purified yeast-expressed ScathL by the Iowa State University Hybridoma Facility using standard procedures (Harlow & Lane, 1988). For specific activity assays, 5 µl of each sample was incubated with 95 µl 0.1 M sodium acetate buffer containing 5 mg azo dye-impregnated collagen (Azocoll; Sigma-Aldrich) ml–1 and 0.003 % PTU at 37 °C for 3 h. Undigested Azocoll was pelleted by centrifugation at 2000 g for 10 min. Absorbance of the supernatant was measured at 520 nm using a VMax Kinetic Microplate Reader (Molecular Devices). Specific activity data were analysed by one-way ANOVA for different virus treatments within a tissue type.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). This suggested that expression of either catalytically active or inactive ScathL together with either -galactosidase or CAT did not change the dose–mortality response.
|
). The ST50 for AcMLF9.ScathL of 47 h p.i. was significantly lower than that of 92 h p.i. for the wild-type C6. However, when the catalytic site mutant of the ScathL protease was expressed (AcMLF9.ScathL.C146A), the ST50 increased to 92 h p.i., similar to that of wild-type C6. This demonstrated that the cysteine protease activity of ScathL plays a key role in the rapid death of infected larvae. Addition of sequences encoding either -galactosidase or CAT resulted in some alteration in the ST50 values of the corresponding viruses with significant differences in some cases following analysis by log-rank comparison (Table 2). Significant differences in ST50 values were seen as expected between viruses expressing active ScathL or inactive ScathL (Table 2). In addition, the ST50 of AcMLF9.ScathL was significantly higher than that of AcMLF9.ScathL.CAT. The ST50 of AcMLF9.ScathL.C146A was also significantly higher than that of AcMLF9.ScathL.C146A.CAT, suggesting that expression of CAT slightly increased the speed of kill by the virus.
|
). The reduced BV titre could result from degradation of BV by ScathL or from some other effect of ScathL on BV assembly and secretion. To evaluate these possibilities, Sf21 cells were infected with wild-type and recombinant viruses and progeny BV titres were measured at different time points. The BV titres of AcMLF9.ScathL within the culture medium of Sf21 cells were not significantly lower than those of the control virus AcMLF9.ScathL.C146A at an m.o.i. of 0.1, but both viruses produced titres that were approximately 1 log lower than that of wild-type virus (P=0.001) (Fig. 2b). At 72 h p.i., approximately 50 % of larvae infected with AcMLF9.ScathL exhibited extensive integumental melanization. To evaluate the impact of this melanization on progeny virus titres, BV from melanized and non-melanized larvae were quantified. Haemolymph from melanized larvae contained a significantly higher BV titre in the haemolymph than non-melanized larvae (Fig. 2c).
|
). More AcMLF9.ScathL polyhedra were present in melanized larvae than non-melanized larvae at 72 h p.i. (Fig. 3b).
|
-galactosidase-galactosidase were studied by monitoring expression of -galactosidase in different tissues (Fig. 4). LacZ was detected in the gut at 6 h p.i. in approximately 30 % of larvae, and at 12 h p.i. all larvae infected with either AcMLF9.ScathL.hsp70/lacZ or AcMLF9.ScathL.C146A.hsp70/lacZ had blue foci of infection in the gut. Although the tracheae are closely associated with the gut, LacZ activity was not observed in this tissue until 18 h p.i., when foci were detected on the major branches of the trachea. However, because of the difficulty in distinguishing between blue staining of the gut and blue staining of the fine branches of the tracheae, some tracheal signals may have been counted as infection of the gut. At 36 h p.i., LacZ signals were seen on the trachea of all larvae examined. LacZ staining was first seen on the fat body and Malpighian tubules at 18 h p.i. in larvae infected with both viruses (Fig. 4b). Staining of these tissues in all larvae was not observed until 48 h p.i. There were no significant differences in the proportion of larvae expressing LacZ in any tissue at any time point.
|
).
Comparison of the extent of infection by CAT assay
Quantification of the extent of viral infection of different tissues was characterized with CAT-expressing viruses. Significant CAT activity was detected after 24 h p.i. in the gut and 30 h p.i. in the fat body and haemolymph of larvae infected with AcMLF9.ScathL.CAT or AcMLF9.ScathL.C146A.CAT compared with the mock-infected larvae (Fig. 5). After 30 h p.i., specific CAT activity increased rapidly in all tissues of larvae infected with either virus. The CAT activity in gut, haemolymph and the fat body of larvae infected with AcMLF9.ScathL.CAT was significantly higher than that infected with AcMLF9.ScathL.C146A.CAT at 42 h p.i. (Fig. 5a–c), but not at other time points. At 48 h p.i., the activity in the fat body of larvae infected with AcMLF9.ScathL.C146A.CAT was higher than that infected with the ScathL-expressing virus (Fig. 5c). Overall, there were no significant differences in CAT activity in any tissue between the two viruses (P=0.2149 for gut, P=0.9425 for haemolymph and P=0.4876 for fat body) across all time points. Melanized larvae infected with AcMLF9.ScathL.CAT exhibited higher CAT activity than non-melanized larvae in all tissues tested (Fig. 5d).
|
). By 48 h p.i., the specific activity in all tested tissues of larvae infected with AcMLF9.ScathL had increased to a significantly higher level than the control treatments (Fig. 6b). This result confirmed that the mutant ScathL.C146A was catalytically inactive. At 24 h p.i., the cysteine protease specific activity was relatively high in the fat body and gut, but low in the plasma of larvae in the mock, wild-type C6 and AcMLF9.ScathL.C146A treatments. The relatively high cysteine protease activity in the fat body and gut of the control treatments may result from endogenous protease activity. Indeed, proteins cross-reacting with the ScathL antiserum in the fat body and gut may include such endogenous proteases (Fig. 6c). The processed form (35 kDa) of both ScathL and ScathL.C146A was detected in all tested tissues, whereas the pro-enzyme (45 kDa) was only consistently detected in the plasma. The presence of the pro-enzyme in the plasma results from secretion of the pro-enzyme from cells with the active form (produced either by autocatalytic cleavage or by endogenous proteases) remaining within the cell. More ScathL was detected by Western blotting for all tissues in melanized than non-melanized larvae, and higher ScathL activity was detected by enzyme assay in melanized compared with non-melanized larvae (Fig. 6d).
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
If ScathL facilitated a more rapid release of BV into the haemocoel from the infected gut and other tissues, a higher titre of BV and larger numbers of polyhedra would be produced in larvae infected with AcMLF9.ScathL at early time points. However, the BV titre of AcMLF9.ScathL in the haemolymph of infected larvae was significantly lower than that of the control virus-infected larvae. Moreover, the overall yield of polyhedra was significantly reduced compared with the control viruses on death of the host insect. These data do not support the hypothesis that AcMLF9.ScathL kills larvae more quickly than the control viruses as a result of more rapid virus dissemination.
It is likely that the significant reduction in polyhedra production by AcMLF9.ScathL resulted in part from the more rapid death of larvae infected with this virus compared with larvae infected with either wild-type or control virus. A similar reduction has been reported previously for fast-killing recombinant AcMNPV clones that express scorpion toxins (Kunimi et al., 1996). Also, the preponderance of data on BV production in larvae and cell culture (Fig. 2) suggests that ScathL expression is accompanied by a moderate reduction in BV titre, although the reason for this reduction is unclear.
The use of -galactosidase expression for a visual comparison of the course of infection of viruses expressing ScathL or ScathL.C146A did not reveal any significant differences in the timing or pathway of infection by the two viruses. In addition, the use of CAT expression to monitor infection did not show a consistent quantitative difference in the extent of infection by ScathL- and ScathL.C146A-expressing viruses.
The results of bioassays with viruses expressing ScathL and an inactivated ScathL mutant demonstrated that the cysteine protease activity of ScathL plays a key role in the accelerated death of AcMLF9.ScathL-infected larvae. ScathL activity was consistently associated with widespread melanization and tissue damage, including ruptured guts and a fragmented fat body. Melanization and tissue damage was not observed in larvae infected with AcMLF9.ScathL.C146A. This association was underscored by a comparison of infected melanized and non-melanized larvae at 48 h p.i. ScathL activity was significantly higher in the tissues of melanized larvae than in those of non-melanized larvae. BV, polyhedra and reporter gene (CAT) activity levels were also higher in melanized larvae, indicating that a higher level of viral gene expression overall had occurred in the melanized larvae compared with the non-melanized larvae. Although larval melanization was associated with ScathL activity, the contribution of melanization to reduced larval survival time remains unclear. The formation of melanin is accompanied by the production of quinones and other cytotoxic reactive species (Carton & Nappi, 1997; Lavine & Strand, 2002). The production of these toxic materials during uncontrolled and widespread melanization may contribute to the pathogenesis of AcMLF9.ScathL infection. We are currently using polydnavirus-derived immunosuppressive genes to separate the effects of melanization and the associated production of toxic free radicals from the potentially lethal impact of BM damage alone.
One possible explanation for why significantly enhanced systemic infection was not observed in AcMLF9.ScathL-infected larvae of H. virescens is that the BM may not be a significant barrier to the dissemination of BV within fifth-instar H. virescens. In Trichoplusia ni, AcMNPV BV appeared to pass through the midgut epithelium and BM directly and establish infection of haemocytes by 4 h p.i. (Granados & Lawler, 1981). However, Keddie et al. (1989) did not find evidence for direct passage of virus into the haemocoel of H. virescens. Engelhard et al. (1994) proposed that baculoviruses bypass the BM by utilizing the tracheae (which penetrate the BM) as a conduit for moving to other tissues (Engelhard et al., 1994). The mechanism of penetration of the BM remains to be determined and there is debate over whether one route predominates over the other (Federici, 1997; Volkman, 1997). Our study showed that a widespread infection of haemocytes in H. virescens larvae did not occur until 30 h p.i., suggesting that the BM surrounding the midgut sheath did serve as a barrier to the passage of virus into the haemocoel.
It is also possible that ScathL was not expressed at a time and a level that would have perforated the BM to an extent necessary to see an effect on systemic infection. The AcMLF9.ScathL virus utilizes the late p6.9 promoter to drive ScathL expression. A virus that expresses ScathL from the early ie-1 promoter does not kill H. virescens larvae faster than wild-type AcMNPV (Harrison & Bonning, 2001). This virus (AcIE1TV3.ScathL) produced far less ScathL activity than AcMLF9.ScathL, indicating that the level of expression may be more important than the timing of expression for survival time reduction.
In summary, expression of a BM-degrading protease did not hasten secondary infection of H. virescens larvae under the conditions used in this study. The significantly enhanced insecticidal efficacy of AcMLF9.ScathL did not appear to be due to accelerated systemic infection by the virus. We confirmed that the cysteine protease activity of ScathL was necessary for the pathology and reduced host survival time observed for AcMLF9.ScathL. Damage to the BM may also trigger the immune response and the role of this response in the death of the insect remains to be addressed.
|
ACKNOWLEDGEMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.[CrossRef][Medline]
Carton, Y. & Nappi, A. J. (1997). Drosophila cellular immunity against parasitoids. Parasitol Today 13, 218–227.[CrossRef][Medline]
Dai, X., Willis, L. G., Huijskens, I., Palli, S. R. & Theilmann, D. A. (2004). The acidic activation domains of the baculovirus transactivators IE1 and IE0 are functional for transcriptional activation in both insect and mammalian cells. J Gen Virol 85, 573–582.
Engelhard, E. K., Kam-Morgan, L. N. W., Washburn, J. O. & Volkman, L. E. (1994). The insect tracheal system: a conduit for the systemic spread of Autographa californica M nuclear polyhedrosis virus. Proc Natl Acad Sci U S A 91, 3224–3227.
Federici, B. A. (1997). Baculovirus pathogenesis. In The Baculoviruses, pp. 33–60. Edited by L. K. Miller. New York: Plenum Press.
Fessler, J. H. & Fessler, L. I. (1989). Drosophila extracellular matrix. Annu Rev Cell Biol 5, 309–339.[CrossRef][Medline]
Finney, D. J. (1971). Probit Analysis. London: Cambridge University Press.
Granados, R. R. & Lawler, K. A. (1981). In vivo pathway of Autographa californica baculovirus invasion and infection. Virology 108, 297–308.
Harlow, E. & Lane, D. (1988). Antibodies: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Harrison, R. L. & Bonning, B. C. (2000). Use of scorpion neurotoxins to improve the insecticidal activity of Rachiplusia ou multicapsid nucleopolyhedrovirus. Biol Control 17, 191–201.
Harrison, R. L. & Bonning, B. C. (2001). Use of proteases to improve the insecticidal activity of baculoviruses. Biol Control 20, 199–209.
Hess, R. T. & Falcon, L. A. (1987). Temporal events in the invasion of the codling moth, Cydia pomonella, by a granulosis virus: an electron microscope study. J Invertebr Pathol 50, 85–105.
Hill-Perkins, M. S. & Possee, R. D. (1990). A baculovirus expression vector derived from the basic protein promoter of Autographa californica nuclear polyhedrosis virus. J Gen Virol 71, 971–976.
Homma, K. & Natori, S. (1996). Identification of substrate proteins for cathepsin L that are selectively hydrolyzed during the differentiation of imaginal discs of Sarcophaga peregrina. Eur J Biochem 240, 443–447.[Medline]
Hughes, P. R. & Wood, H. A. (1981). A synchronous peroral technique for the bioassay of insect viruses. J Invertebr Pathol 37, 154–159.
Jin, H. (2002). Polyhedral envelope protein mutants in Rachiplusia ou multi-nucleocapsid nucleopolyhedrovirus. MSc thesis, Iowa State University, Ames, IA, USA.
Kalbfleisch, J. D. & Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. New York: Wiley.
Kamita, S. G., Kang, K.-D., Hammock, B. D. & Inceoglu, A. B. (2005). Genetically modified baculoviruses for pest insect control. In Comprehensive Molecular Insect Science, pp. 271–322. Edited by L. I. Gilbert, K. Iatrou & S. S. Gill. Oxford: Elsevier.
Keddie, B. A., Aponte, G. W. & Volkman, L. E. (1989). The pathway of infection of Autographa californica nuclear polyhedrosis virus in an insect host. Science 243, 1728–1730.
Kitts, P. A., Ayres, M. D. & Possee, R. D. (1990). Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. Nucleic Acids Res 18, 5667–5672.
Kunimi, Y., Fuxa, J. R. & Hammock, B. D. (1996). Comparison of wild type and genetically engineered nuclear polyhedrosis viruses of Autographa californica for mortality, virus replication and polyhedra production in Trichoplusia ni larvae. Entomol Exp Appl 81, 251–257.
Lavine, M. D. & Strand, M. R. (2002). Insect hemocytes and their role in immunity. Insect Biochem Mol Biol 32, 1295–1309.[CrossRef][Medline]
Moscardi, F. (1999). Assessment of the application of baculoviruses for control of Lepidoptera. Annu Rev Entomol 44, 257–289.[CrossRef][Medline]
O'Reilly, D. R., Miller, L. K. & Luckow, V. A. (1992). Baculovirus Expression Vectors: a Laboratory Manual. New York: Freeman.
Reddy, J. T. & Locke, M. (1990). The size limited penetration of gold particles through insect basal laminae. J Insect Physiol 36, 397–407.
Robertson, J. L. & Preisler, H. K. (1992). Pesticide Bioassays with Arthropods. Baton Rouge, LA: CRC Press.
Romoser, W. S., Turell, M. J., Lerdthusnee, K., Neira, M., Dohm, D., Ludwig, G. & Wasieloski, L. (2005). Pathogenesis of Rift Valley fever virus in mosquitoes – tracheal conduits and the basal lamina as an extra-cellular barrier. Arch Virol Suppl 89–100.
SAS Institute (1990). SAS User's Guide, Version 6, 4th edn. Cary, NC: SAS Institute.
Smith-Johannsen, H., Witkiewicz, H. & Iatrou, K. (1986). Infection of silkmoth follicular cells with Bombyx mori nuclear polyhedrosis virus. J Invertebr Pathol 48, 74–84.
Summers, M. D. & Smith, G. E. (1987). A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. In Texas Agricultural Experiment Station Bulletin, No. 1555, pp. 14–16. College Station, TX: Texas A & M University.
Trudeau, D., Washburn, J. O. & Volkman, L. E. (2001). Central role of hemocytes in Autographa californica M nucleopolyhedrovirus pathogenesis in Heliothis virescens and Helicoverpa zea. J Virol 75, 996–1003.
Vaughn, J. L., Goodwin, R. H., Tompkins, G. J. & McCawley, P. (1977). The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera: Noctuidae). In Vitro 13, 213–217.[Medline]
Volkman, L. E. (1997). Nucleopolyhedrovirus interactions with their insect hosts. Adv Virus Res 48, 313–348.[Medline]
Wang, X. Z., Ooi, B. G. & Miller, L. K. (1991). Baculovirus vectors for multiple gene expression and for occluded virus production. Gene 100, 131–137.[CrossRef][Medline]
Washburn, J. O., Kirkpatrick, B. A. & Volkman, L. E. (1995). Comparative pathogenesis of Autographa californica M nuclear polyhedrosis virus in larvae of Trichoplusia ni and Heliothis virescens. Virology 209, 561–568.[CrossRef][Medline]
Washburn, J. O., Haas-Stapleton, E. J., Tan, F. F., Beckage, N. E. & Volkman, L. E. (2000). Co-infection of Manduca sexta larvae with polydnavirus from Cotesia congregata increases susceptibility to fatal infection by Autographa californica M. nucleopolyhedrovirus. J Insect Physiol 46, 179–190.[CrossRef][Medline]
Wickham, T. J., Davis, T., Granados, R. R., Shuler, M. L. & Wood, H. A. (1992). Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus system. Biotechnol Prog 8, 391–396.[CrossRef][Medline]
Yurchenco, P. D. & O'Rear, J. (1993). Supramolecular organization of basement membranes. In Molecular and Cellular Aspects of Basement Membranes, pp. 19–47. Edited by D. H. Rohrbach & R. Timpl. New York: Academic Press.
Received 7 November 2006;
accepted 21 December 2006.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
